ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Achieve Life Sciences Completes FDA Meeting on Cytisinicline for Smoking Cessation
December 27, 2019Achieve Life Sciences announced an update on the cytisinicline clinical development program.Following discussions with the Food and Drug Administration (FDA) ... -
Achieve Life Sciences Announces Positive Results for Simplified Cytisinicline Dosing Schedule
June 13, 2019Achieve Life Sciences has announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the 254-subject, ORCA-1 trial is the selection of 3.0 mg, three times daily (TID) for Phase 3 development.
Pharma Sources Insight January 2025
